3 Catalysts That Could Send Teva Stock to $40 and Beyond [Globe and Mail, The (Toronto, Canada)]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Globe and Mail, The
Teva's specialty drugs continue to gain momentum. The drugmaker should also experience a biosimilar boom over the next couple of years. After a multi-year slump, Teva Pharmaceutical Industries Limited (NYSE: TEVA) is on a roll. Shares of the Israel-based drugmaker have soared more than 130% over the last 12 months. Could Teva's momentum continue? Wall Street thinks so. Twelve of the 15 analysts surveyed by S&P Global (NYSE: SPGI) in April rated the pharmaceutical stock as a "buy" or "strong buy." There are three specific catalysts that could send Teva stock to $40 -- and perhaps beyond. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Image source: Getty Images. 1. Olanzapine approval Roughly three months ago, the U.S. Food and Drug Administration (FDA) accepted Teva's New Drug Application (NDA) for ol
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Teva Pharmaceutical Industries Limited (TEVA): David Einhorn Trims Holding [Yahoo! Finance]Yahoo! Finance
- How Teva Pharmaceutical Industries (TEVA) Story Is Shifting With Duvakitug R&D And Biosimilars [Yahoo! Finance]Yahoo! Finance
- Teva Launches Home Groundâ„¢ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care PartnersGlobeNewswire
- Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable ClinicsGlobeNewswire
- Teva: The Market Is Pricing The Past, Not The Pipeline - Initiating Buy [Seeking Alpha]Seeking Alpha
TEVA
Earnings
- 1/28/26 - Beat
TEVA
Sec Filings
- 3/31/26 - Form DEFA14A
- 3/31/26 - Form ARS
- 3/31/26 - Form DEF
- TEVA's page on the SEC website